story of the week
Longitudinal Stability of the JCV Antibody Index in Individuals With MS Treated With Natalizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis
Mult Scler Relat Disord 2022 Dec 01;68(xx)104251, M Gaughan, M Gilligan, I Patterson, I McGurgan, SM Yap, N Tubridy, C McGuiganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.